发明名称 |
4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR |
摘要 |
Novel quinoline compounds pharmaceutical compositions containing such compounds and their use in therapy. |
申请公布号 |
US2014171462(A1) |
申请公布日期 |
2014.06.19 |
申请号 |
US201214237905 |
申请日期 |
2012.08.15 |
申请人 |
GlaxoSmithKline LLC |
发明人 |
Demont Emmanuel Hubert;Jones Katherine Louise;Watson Robert J. |
分类号 |
C07D471/04;A61K31/4745 |
主分类号 |
C07D471/04 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound of formula (I) which is 4-(8-methoxy-1-(1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazoleor a salt thereof.
|
地址 |
Wilmington DE US |